COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
LTIMindtree shares plunged 13% today. Should you sell stock post weak Q3, guidance?

LTIMindtree shares plunged 13% today. Should you sell stock post weak Q3, guidance?

LTIMindtree needs to demonstrate visible translation of synergies to deals and revenue, and increase the growth gap with Tier 1 peers to justify premium valuations, said Kotak Institutional Equities.

Amit Mudgill
Amit Mudgill
  • Updated Jan 18, 2024 10:11 AM IST
LTIMindtree shares plunged 13% today. Should you sell stock post weak Q3, guidance? LTIMindtree target price: Motilal Oswal said the near-term slowdown in discretionary spending and its meaningful exposure to BFS would have an adverse impact on its growth performance.

Shares of LTIMindtree Ltd took a beating in Thursday's trade after a weak set of quarterly results and concerning management guidance. Analysts said the management continued to see elongated decision-making cycles, and is expecting delays in deal ramp-ups. Growth in Q4 is also expected to be along similar lines as Q3, with furloughs flowing into Q4 as well, they cited.

Advertisement

LTIMindtree needs to demonstrate visible translation of synergies to deals and revenue, and increase the growth gap with Tier 1 peers to justify premium valuations, said Kotak Institutional Equities.

The stock plunged 13.4 per cent to hit a low of Rs 5,436 on BSE. A shift in the outlook on demand and profitability is disappointing and drives 4-5 per cent EPS downgrades for FY2024-26E, Kotak said.  The stock trades at expensive valuations of 27 times FY2025 and will correct after poor results, it warned while suggesting a fair value of Rs 5,500 for the stock against Rs 5,910 earlier.

"EBIT margin for the quarter came in at 15.4 per cent due to higher-than-anticipated furloughs, lower working days and seasonal pass-through of revenue. The management has pushed out the Q4FY24 EBIT margin target of 17–18 per cent by a few quarters—as it expects furloughs in Q4 too along with investments in business and deal ramp-ups. FY25 margin target of 17–18 per cent too has been pushed out to ‘medium term’," Nuvama Institutional Equities said.

Advertisement

Motilal Oswal said the near-term slowdown in discretionary spending and its meaningful exposure to BFS would have an adverse impact on its growth performance. It expects a 9.7 per cent CAGR in dollar revenue over FY23-26.

"Additionally, due to the company’s strategic decision to defer the aspirational margin band, we cut our earnings estimate. We estimate a PAT CAGR of 13 per cent over FY23-26. We value the stock at 30 times FY26E EPS. The current valuation of 29 times FY26E EPS limits any meaningful upside from the CMP. We reiterate our Neutral rating with a target of Rs 6,600," it said.

Nomura India said LTIMindtree noted that given its utilization level has now touched 87.4 per cent and is above its comfort zone of 85 per cent it would need to start hiring. In large cost take-out deals, employee capacity has to be first built, anticipating a transition. "This will delay LTIM’s aspiration of hitting 17-18% EBIT margin in 4QFY24 by a “few” quarters. We lower our EBIT margin forecast by 20-50 bps for FY24-26F. We expect EBIT margin of 16.1-17.6 per cent over FY24-26F," it said.

Advertisement

Also read: Stock recommendations by analyst for Jan 18, 2024: Welspun Corp, L&T Fin and Apollo Hospitals

Also read: Persistent Systems shares in news as IT firm to consider stock split on January 20   

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Published on: Jan 18, 2024 9:54 AM IST
Post a comment0